250 related articles for article (PubMed ID: 31019079)
1. HIV-1 Vpr counteracts HLTF-mediated restriction of HIV-1 infection in T cells.
Yan J; Shun MC; Zhang Y; Hao C; Skowronski J
Proc Natl Acad Sci U S A; 2019 May; 116(19):9568-9577. PubMed ID: 31019079
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Vpr Reprograms CLR4
Yan J; Shun MC; Hao C; Zhang Y; Qian J; Hrecka K; DeLucia M; Monnie C; Ahn J; Skowronski J
mBio; 2018 Oct; 9(5):. PubMed ID: 30352932
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Vpx-Mediated SAMHD1 and Vpr-Mediated Host Helicase Transcription Factor Degradation by Selective Disruption of Viral CRL4 (DCAF1) E3 Ubiquitin Ligase Assembly.
Wang H; Guo H; Su J; Rui Y; Zheng W; Gao W; Zhang W; Li Z; Liu G; Markham RB; Wei W; Yu XF
J Virol; 2017 May; 91(9):. PubMed ID: 28202763
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 and HIV-2 exhibit divergent interactions with HLTF and UNG2 DNA repair proteins.
Hrecka K; Hao C; Shun MC; Kaur S; Swanson SK; Florens L; Washburn MP; Skowronski J
Proc Natl Acad Sci U S A; 2016 Jul; 113(27):E3921-30. PubMed ID: 27335459
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Vpr protein directly loads helicase-like transcription factor (HLTF) onto the CRL4-DCAF1 E3 ubiquitin ligase.
Zhou X; DeLucia M; Hao C; Hrecka K; Monnie C; Skowronski J; Ahn J
J Biol Chem; 2017 Dec; 292(51):21117-21127. PubMed ID: 29079575
[TBL] [Abstract][Full Text] [Related]
6. Evidence for Vpr-dependent HIV-1 replication in human CD4+ CEM.NKR T-cells.
Zhou T; Dang Y; Baker JJ; Zhou J; Zheng YH
Retrovirology; 2012 Nov; 9():93. PubMed ID: 23134572
[TBL] [Abstract][Full Text] [Related]
7. Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.
Barbosa JAF; Sparapani S; Boulais J; Lodge R; Cohen ÉA
J Virol; 2021 Jul; 95(15):e0097120. PubMed ID: 34011540
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Accessory Protein Vpr Interacts with REAF/RPRD2 To Mitigate Its Antiviral Activity.
Gibbons JM; Marno KM; Pike R; Lee WJ; Jones CE; Ogunkolade BW; Pardieu C; Bryan A; Fu RM; Warnes G; Rowley PA; Sloan RD; McKnight Á
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776272
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages.
Lahouassa H; Blondot ML; Chauveau L; Chougui G; Morel M; Leduc M; Guillonneau F; Ramirez BC; Schwartz O; Margottin-Goguet F
Proc Natl Acad Sci U S A; 2016 May; 113(19):5311-6. PubMed ID: 27114546
[TBL] [Abstract][Full Text] [Related]
10. Virion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells.
Miller CM; Akiyama H; Agosto LM; Emery A; Ettinger CR; Swanstrom RI; Henderson AJ; Gummuluru S
J Virol; 2017 Jul; 91(13):. PubMed ID: 28424288
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Temporal Viromics of an Inducible HIV-1 Model Yields Insight to Global Host Targets and Phospho-Dynamics Associated with Protein Vpr.
Lapek JD; Lewinski MK; Wozniak JM; Guatelli J; Gonzalez DJ
Mol Cell Proteomics; 2017 Aug; 16(8):1447-1461. PubMed ID: 28606917
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Vpr hijacks EDD-DYRK2-DDB1
Hossain D; Ferreira Barbosa JA; Cohen ÉA; Tsang WY
J Biol Chem; 2018 Jun; 293(24):9448-9460. PubMed ID: 29724823
[TBL] [Abstract][Full Text] [Related]
13. Defining the interactions and role of DCAF1/VPRBP in the DDB1-cullin4A E3 ubiquitin ligase complex engaged by HIV-1 Vpr to induce a G2 cell cycle arrest.
Gérard FC; Yang R; Romani B; Poisson A; Belzile JP; Rougeau N; Cohen ÉA
PLoS One; 2014; 9(2):e89195. PubMed ID: 24558487
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 Vpr activates host CRL4-DCAF1 E3 ligase to degrade histone deacetylase SIRT7.
Zhou X; Monnie C; DeLucia M; Ahn J
Virol J; 2021 Mar; 18(1):48. PubMed ID: 33648539
[TBL] [Abstract][Full Text] [Related]
15. Nuclear localization of Vpr is crucial for the efficient replication of HIV-1 in primary CD4+ T cells.
Iijima S; Nitahara-Kasahara Y; Kimata K; Zhong Zhuang W; Kamata M; Isogai M; Miwa M; Tsunetsugu-Yokota Y; Aida Y
Virology; 2004 Oct; 327(2):249-61. PubMed ID: 15351213
[TBL] [Abstract][Full Text] [Related]
16. The SMC5/6 complex compacts and silences unintegrated HIV-1 DNA and is antagonized by Vpr.
Dupont L; Bloor S; Williamson JC; Cuesta SM; Shah R; Teixeira-Silva A; Naamati A; Greenwood EJD; Sarafianos SG; Matheson NJ; Lehner PJ
Cell Host Microbe; 2021 May; 29(5):792-805.e6. PubMed ID: 33811831
[TBL] [Abstract][Full Text] [Related]
17. The HIV-1 Vif protein mediates degradation of Vpr and reduces Vpr-induced cell cycle arrest.
Wang J; Shackelford JM; Selliah N; Shivers DK; O'Neill E; Garcia JV; Muthumani K; Weiner D; Yu XF; Gabuzda D; Finkel TH
DNA Cell Biol; 2008 May; 27(5):267-77. PubMed ID: 18462066
[TBL] [Abstract][Full Text] [Related]
18. Vpr Targets TET2 for Degradation by CRL4
Lv L; Wang Q; Xu Y; Tsao LC; Nakagawa T; Guo H; Su L; Xiong Y
Mol Cell; 2018 Jun; 70(5):961-970.e5. PubMed ID: 29883611
[TBL] [Abstract][Full Text] [Related]
19. Interactions with DCAF1 and DDB1 in the CRL4 E3 ubiquitin ligase are required for Vpr-mediated G2 arrest.
Hakata Y; Miyazawa M; Landau NR
Virol J; 2014 Jun; 11():108. PubMed ID: 24912982
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of Vpr on single-cycle and spreading HIV-1 infections in CD4+ T-cells and dendritic cells.
de Silva S; Planelles V; Wu L
PLoS One; 2012; 7(5):e35385. PubMed ID: 22570689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
